Skip to main content

Evoke Pharma Inc

EVOKDelisted Dec 17, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001403708

Evoke Pharma Inc was delisted on Dec 17, 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Evoke Pharma Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of EVOK: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders2522−3
Shares4.28M4.50M+224.4K (+5.2%)
Value$7.83M$6.17M−$1.66M (−21.2%)

New holders (5)

Institutions that held Evoke Pharma Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to EVOK in Q2 2021
InstitutionSharesValue% of portfolio
Raymond James Financial Services Advisors, Inc.119,190$163.0K0.00%
Sabby Management, LLC47,431$65.0K0.01%
Citadel Advisors LLC39,129$54.0K0.00%
Federation des caisses Desjardins du Quebec60$820.00%
FMR LLC49$00.00%

Sold out (8)

Institutions that held Evoke Pharma Inc at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of EVOK in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Creative Planning100,000$183.0K
California Public Employees Retirement System36,700$67.0K
Jane Street Group, LLC18,044$33.0K
United Capital Financial Advisers, LLC14,000$26.0K
Two Sigma Advisers, LP12,100$22.0K
Ogorek Anthony Joseph3,540$6.00K
Deutsche Bank AG490$1.00K
O'Shaughnessy Asset Management, LLC528$1.00K